Literature DB >> 22284972

Suboptimal glycemic control in type 2 diabetes: a key role for anhedonia?

G Nefs1, F Pouwer, J Denollet, H Kramer, C J M Wijnands-van Gent, V J M Pop.   

Abstract

Recent studies examining the relationship between depression and glycosylated hemoglobin (HbA(1c)) concentrations in patients with type 2 diabetes have yielded mixed findings. One explanation may lie in the heterogeneity of depression. Therefore, we examined whether distinct features of depression were differentially associated with suboptimal glycemic control. Cross-sectional baseline data from a dynamic cohort study of primary care patients with type 2 diabetes from the Eindhoven region, The Netherlands, were analyzed. A total of 5772 individuals completed baseline measurements of demographic, clinical, lifestyle and psychological factors between 2005 and 2009. The Edinburgh Depression Scale was used to assess symptoms of depressed mood, anhedonia and anxiety. Suboptimal glycemic control was defined as HbA(1c) values ≥7%, with 29.8% of the sample (n=1718) scoring above this cut-off. In univariate logistic regression analyses, anhedonia was significantly associated with suboptimal glycemic control (OR 1.29, 95% CI 1.09-1.52), while both depressed mood (OR 1.04, 0.88-1.22) and anxiety (OR 0.99, 0.83-1.19) were not. The association between anhedonia and glycemic control remained after adjustment for the other depression measures (OR 1.33, 1.11-1.59). Alcohol consumption and physical activity met criteria for mediation, but did not attenuate the association between anhedonia and glycemic control by more than 5%. Although diabetes duration was identified as a confounder and controlled for, the association was still significant (OR 1.20, 1.01-1.43). Studying different symptoms of depression, in particular anhedonia, may add to a better understanding of the relationship between depression and glycemic control. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284972     DOI: 10.1016/j.jpsychires.2012.01.013

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  14 in total

1.  Effect of streptozotocin-induced diabetes on performance on a progressive ratio schedule.

Authors:  Lourdes Valencia-Torres; C M Bradshaw; Arturo Bouzas; Enrique Hong; Vladimir Orduña
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

2.  Measuring Anhedonia in Adolescents: A Psychometric Analysis.

Authors:  Adam M Leventhal; Jennifer B Unger; Janet Audrain-McGovern; Steve Sussman; Heather E Volk; David R Strong
Journal:  J Pers Assess       Date:  2015-04-20

3.  Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule.

Authors:  G Bezzina; S Body; T H C Cheung; C L Hampson; C M Bradshaw; J C Glennon; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2014-08-19       Impact factor: 4.530

Review 4.  Anhedonia: a concept analysis.

Authors:  Nancy Ho; Marilyn Sommers
Journal:  Arch Psychiatr Nurs       Date:  2013-04-24       Impact factor: 2.218

5.  An online positive affect skills intervention reduces depression in adults with type 2 diabetes.

Authors:  Michael A Cohn; Martha E Pietrucha; Laura R Saslow; Jen R Hult; Judith T Moskowitz
Journal:  J Posit Psychol       Date:  2014-01-01

6.  Parental History of Diabetes, Positive Affect, and Diabetes Risk in Adults: Findings from MIDUS.

Authors:  Vera K Tsenkova; Arun S Karlamangla; Carol D Ryff
Journal:  Ann Behav Med       Date:  2016-12

7.  Depressive symptom dimensions and medication non-adherence in suboptimally controlled type 2 diabetes.

Authors:  Claire J Hoogendoorn; Amit Shapira; Juan F Roy; Elizabeth A Walker; Hillel W Cohen; Jeffrey S Gonzalez
Journal:  J Diabetes Complications       Date:  2018-12-07       Impact factor: 2.852

8.  Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Δ⁹-tetrahydrocannabinol (THC).

Authors:  C M Olarte-Sánchez; L Valencia-Torres; H J Cassaday; C M Bradshaw; E Szabadi
Journal:  Behav Processes       Date:  2015-01-28       Impact factor: 1.777

9.  Prevalence and characteristics of depressive disorders in type 1 diabetes.

Authors:  Line Iden Berge; Trond Riise; Oivind Hundal; Ketil Joachim Odegaard; Steven Dilsaver; Anders Lund
Journal:  BMC Res Notes       Date:  2013-12-19

10.  Diabetes MILES--The Netherlands: rationale, design and sample characteristics of a national survey examining the psychosocial aspects of living with diabetes in Dutch adults.

Authors:  Giesje Nefs; Mariska Bot; Jessica L Browne; Jane Speight; François Pouwer
Journal:  BMC Public Health       Date:  2012-10-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.